MPL antibody (Extracellular Domain)

Catalog No. ABIN967682

The Mouse Monoclonal anti-MPL antibody has been validated for WB and FACS. It is suitable to detect MPL in samples from Human. There are 4+ publications available.

Quick Overview for MPL antibody (Extracellular Domain) (ABIN967682)

Target: MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This MPL antibody is un-conjugated

Application: Western Blotting (WB), Flow Cytometry (FACS)

Clone: 1-78-1

Product Details anti-MPL Antibody

Binding Specificity: Extracellular Domain

Brand: BD Pharmingen™

Characteristics: 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.

Purification: The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Immunogen: Human c-Mpl extracellular domain

Isotype: IgG1 kappa

Application Details

Comment:

Related Products: ABIN967389

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Aqueous buffered solution containing ≤0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store undiluted at 4°C.

References for anti-MPL antibody (ABIN967682)

Abbott, Huang, Ellison, Chen, Arora, Szilvassy, Wei: "Mouse monoclonal antibodies against human c-Mpl and characterization for flow cytometry applications." in: Hybridoma (2005), Vol. 29, Issue 2, pp. 103-13, (2010) (PubMed).

Deng, Banu, Malloy, Hass, Wang, Cavacini, Eaton, Avraham: "An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis." in: Blood, Vol. 92, Issue 6, pp. 1981-8, (1998) (PubMed).

Gotoh, Ritchie, Takahira, Broxmeyer: "Thrombopoietin and erythropoietin activate inside-out signaling of integrin and enhance adhesion to immobilized fibronectin in human growth-factor-dependent hematopoietic cells." in: Annals of hematology, Vol. 75, Issue 5-6, pp. 207-13, (1998) (PubMed).

Broudy, Lin, Fox, Taga, Saito, Kaushansky: "Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit." in: Blood, Vol. 88, Issue 6, pp. 2026-32, (1996) (PubMed).

Target Details for MPL

Target: MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))

Alternative Name: CD110

Background: The 1.78.1 monoclonal antibody specifically binds to the human Thrombopoietin Receptor (TPO-R) that is also know as the Myeloproliferative leukemia protein (c-Mpl) or CD110. CD110 is a type I transmembrane protein and a member of the hematopoietin receptor family. It is expressed on hematopoietic stem cells, a subfraction of hematopoietic precursor cells, cells of the megakaryocytic lineage and platelets. CD110 serves as a receptor for thrombopoietin. Upon binding of thrombopoietin to CD110, megakaryocyte proliferation and differentiation is induced and stem cells are protected from apoptosis.
Synonyms: C-MPL, MPL, MPLV, TPOR, Thrombopoietin receptor

Molecular Weight: 65-72 kDa (HEL cells) and 80-90 kDa (Platelets)

Pathways: JAK-STAT Signaling